286 related articles for article (PubMed ID: 16944706)
1. [Effect of theophylline on respiratory function in patients with chronic obstructive lung disease].
Sooronbaev TM; Altymysheva AT; Shabykeeva SB; Kadyraliev ZhK; Mirrakhimov MM
Probl Tuberk Bolezn Legk; 2006; (7):13-6. PubMed ID: 16944706
[TBL] [Abstract][Full Text] [Related]
2. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
Tashkin DP
Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
[TBL] [Abstract][Full Text] [Related]
3. Effect of theophylline in chronic obstructive lung disease.
Umut S; Gemicioğlu B; Yildirim N; Barlas A; Ozüner Z
Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):149-52. PubMed ID: 1592541
[TBL] [Abstract][Full Text] [Related]
4. Influence of chronic obstructive pulmonary disease on postoperative lung function and complications in patients undergoing operations for primary non-small cell lung cancer.
Subotic DR; Mandaric DV; Eminovic TM; Gajic MM; Mujovic NM; Atanasijadis ND; Dzeletovic PP; Andric LD; Bulajic BM; Dimitrijevic ID; Sobic DP
J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1292-9. PubMed ID: 17976465
[TBL] [Abstract][Full Text] [Related]
5. Treatment of moderate chronic obstructive pulmonary disease (stable) with doxofylline compared with slow release theophylline--a multicentre trial.
Santra CK
J Indian Med Assoc; 2008 Dec; 106(12):791-2, 794. PubMed ID: 19370950
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment with theophylline reduces neutrophils, interleukin-8 and tumor necrosis factor-alpha in the sputum of patients with chronic obstructive pulmonary disease.
Iiboshi H; Ashitani J; Katoh S; Sano A; Matsumoto N; Mukae H; Nakazato M
Pulm Pharmacol Ther; 2007; 20(1):46-51. PubMed ID: 16413994
[TBL] [Abstract][Full Text] [Related]
7. Effects of tiotropium or combined therapy with salmeterol on hyperinflation in COPD.
Eguchi Y; Tateishi Y; Umeda N; Yoshikawa T; Kamoi H; Kanazawa H; Kudoh S; Hirata K; Fujimoto S
Osaka City Med J; 2007 Jun; 53(1):25-34. PubMed ID: 17867631
[TBL] [Abstract][Full Text] [Related]
8. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.
Lee TA; Schumock GT; Bartle B; Pickard AS
Pharmacotherapy; 2009 Sep; 29(9):1039-53. PubMed ID: 19698009
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis and management of chronic obstructive pulmonary disease].
Sato N; Kanazawa M
Kyobu Geka; 2007 Aug; 60(9):841-8. PubMed ID: 17703625
[TBL] [Abstract][Full Text] [Related]
10. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
11. [Clinical trial of ventax (long-acting theophylline) in chronic obstructive bronchitis].
Nikitina AV; Karpukhina EP; Lapygina MV; Evstratov AI
Klin Med (Mosk); 1997; 75(1):40-1. PubMed ID: 9082058
[TBL] [Abstract][Full Text] [Related]
12. Effects of inhaled therapies on health-related quality of life in stable chronic obstructive pulmonary disease.
Antoniu SA
Expert Rev Pharmacoecon Outcomes Res; 2010 Apr; 10(2):155-62. PubMed ID: 20384562
[TBL] [Abstract][Full Text] [Related]
13. Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone.
Kurashima K; Hara K; Yoneda K; Kanauchi T; Kagiyama N; Tokunaga D; Takayanagi N; Ubukata M; Sugita Y
Respirology; 2009 Mar; 14(2):239-44. PubMed ID: 19210650
[TBL] [Abstract][Full Text] [Related]
14. Clinical course of chronic obstructive pulmonary disease: review of therapeutic interventions.
Anzueto A
Am J Med; 2006 Oct; 119(10 Suppl 1):46-53. PubMed ID: 16996899
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
[TBL] [Abstract][Full Text] [Related]
16. [Comparing the bronchodilating effects of ipratropium bromide and theophylline].
Dai L; Li X; Yang Y
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct; 21(10):609-11. PubMed ID: 11477880
[TBL] [Abstract][Full Text] [Related]
17. [Pathophysiological basis for using bronchodilatators in COPD].
Similowski T
Rev Pneumol Clin; 2002 Sep; 58(4 Pt 2):2S5-9. PubMed ID: 12458312
[No Abstract] [Full Text] [Related]
18. Mechanism of bronchodilator effect in chronic airflow limitation.
Jaeschke R; Guyatt GH; Singer J; Keller J; Newhouse MT
CMAJ; 1991 Jan; 144(1):35-9. PubMed ID: 1984814
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of acute bronchodilator tests in patients with chronic obstructive lung disease and bronchial asthma].
Vizel' AA; Vizel' IIu; Vizel' EA
Probl Tuberk Bolezn Legk; 2005; (7):40-4. PubMed ID: 16130428
[TBL] [Abstract][Full Text] [Related]
20. [The pathogenesis of chronic obstructive pulmonary disease, steroid resistance and the place of theophylline in the treatment].
Bayram H
Tuberk Toraks; 2009; 57(1):115-24. PubMed ID: 19533448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
